Asia-Pacific Specialty Injectable Generics Market Report 2017

REPORT ID 3893

Asia-Pacific Specialty Injectable Generics Market Report 2017

Publish Date

14-Dec-17

Pages

110

Format

Electronic (PDF)

Full report description

In this report, the Asia-Pacific Specialty Injectable Generics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Specialty Injectable Generics for these regions, from 2012 to 2022 (forecast), including
    China
    Japan
    South Korea
    Taiwan
    India
    Southeast Asia
    Australia

Asia-Pacific Specialty Injectable Generics market competition by top manufacturers/players, with Specialty Injectable Generics sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Pfizer
    Fresenius
    Mylan N.V.
    Teva Pharmaceutical
    Hikma Pharmaceuticals
    Novartis AG
    Uman Pharma
    Baxter
    Par Pharmaceutical
    Sagent Pharmaceuticals
    Teligent

On the basis of product, this report displays the sales volum, revenue, product price, market share and growth rate of each type, primarily split into
    Type I
    Type II
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Oncology
    Cardiovascular
    Central Nervous System
    Infectious Diseases
    Autoimmune Disorders

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of contents

Table of Contents

Asia-Pacific Specialty Injectable Generics Market Report 2017
1 Specialty Injectable Generics Overview
    1.1 Product Overview and Scope of Specialty Injectable Generics
    1.2 Classification of Specialty Injectable Generics by Product Category
        1.2.1 Asia-Pacific Specialty Injectable Generics Market Size (Sales) Comparison by Types (2012-2022)
        1.2.2 Asia-Pacific Specialty Injectable Generics Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 
        1.2.4 
    1.3 Asia-Pacific Specialty Injectable Generics Market by Application/End Users
        1.3.1 Asia-Pacific Specialty Injectable Generics Sales (Volume) and Market Share Comparison by Applications (2012-2022)
        1.3.2 Oncology
        1.3.3 Cardiovascular
        1.3.4 Central Nervous System
        1.3.5 Infectious Diseases
        1.3.6 Autoimmune Disorders
    1.4 Asia-Pacific Specialty Injectable Generics Market by Region
        1.4.1 Asia-Pacific Specialty Injectable Generics Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 China Status and Prospect (2012-2022)
        1.4.3 Japan Status and Prospect (2012-2022)
        1.4.4 South Korea Status and Prospect (2012-2022)
        1.4.5 Taiwan Status and Prospect (2012-2022)
        1.4.6 India Status and Prospect (2012-2022)
        1.4.7 Southeast Asia Status and Prospect (2012-2022)
        1.4.8 Australia Status and Prospect (2012-2022)
    1.5 Asia-Pacific Market Size (Value and Volume) of Specialty Injectable Generics (2012-2022)
        1.5.1 Asia-Pacific Specialty Injectable Generics Sales and Growth Rate (2012-2022)
        1.5.2 Asia-Pacific Specialty Injectable Generics Revenue and Growth Rate (2012-2022)

2 Asia-Pacific Specialty Injectable Generics Competition by Players/Suppliers, Region, Type and Application
    2.1 Asia-Pacific Specialty Injectable Generics Market Competition by Players/Suppliers
        2.1.1 Asia-Pacific Specialty Injectable Generics Sales Volume and Market Share of Key Players/Suppliers (2012-2017)
        2.1.2 Asia-Pacific Specialty Injectable Generics Revenue and Share by Players/Suppliers (2012-2017)
    2.2 Asia-Pacific Specialty Injectable Generics (Volume and Value) by Type
        2.2.1 Asia-Pacific Specialty Injectable Generics Sales and Market Share by Type (2012-2017)
        2.2.2 Asia-Pacific Specialty Injectable Generics Revenue and Market Share by Type (2012-2017)
    2.3 Asia-Pacific Specialty Injectable Generics (Volume) by Application
    2.4 Asia-Pacific Specialty Injectable Generics (Volume and Value) by Region
        2.4.1 Asia-Pacific Specialty Injectable Generics Sales and Market Share by Region (2012-2017)
        2.4.2 Asia-Pacific Specialty Injectable Generics Revenue and Market Share by Region (2012-2017)

3 China Specialty Injectable Generics (Volume, Value and Sales Price)
    3.1 China Specialty Injectable Generics Sales and Value (2012-2017)
        3.1.1 China Specialty Injectable Generics Sales Volume and Growth Rate (2012-2017)
        3.1.2 China Specialty Injectable Generics Revenue and Growth Rate (2012-2017)
        3.1.3 China Specialty Injectable Generics Sales Price Trend (2012-2017)
    3.2 China Specialty Injectable Generics Sales Volume and Market Share by Type
    3.3 China Specialty Injectable Generics Sales Volume and Market Share by Application

4 Japan Specialty Injectable Generics (Volume, Value and Sales Price)
    4.1 Japan Specialty Injectable Generics Sales and Value (2012-2017)
        4.1.1 Japan Specialty Injectable Generics Sales Volume and Growth Rate (2012-2017)
        4.1.2 Japan Specialty Injectable Generics Revenue and Growth Rate (2012-2017)
        4.1.3 Japan Specialty Injectable Generics Sales Price Trend (2012-2017)
    4.2 Japan Specialty Injectable Generics Sales Volume and Market Share by Type
    4.3 Japan Specialty Injectable Generics Sales Volume and Market Share by Application

5 South Korea Specialty Injectable Generics (Volume, Value and Sales Price)
    5.1 South Korea Specialty Injectable Generics Sales and Value (2012-2017)
        5.1.1 South Korea Specialty Injectable Generics Sales Volume and Growth Rate (2012-2017)
        5.1.2 South Korea Specialty Injectable Generics Revenue and Growth Rate (2012-2017)
        5.1.3 South Korea Specialty Injectable Generics Sales Price Trend (2012-2017)
    5.2 South Korea Specialty Injectable Generics Sales Volume and Market Share by Type
    5.3 South Korea Specialty Injectable Generics Sales Volume and Market Share by Application

6 Taiwan Specialty Injectable Generics (Volume, Value and Sales Price)
    6.1 Taiwan Specialty Injectable Generics Sales and Value (2012-2017)
        6.1.1 Taiwan Specialty Injectable Generics Sales Volume and Growth Rate (2012-2017)
        6.1.2 Taiwan Specialty Injectable Generics Revenue and Growth Rate (2012-2017)
        6.1.3 Taiwan Specialty Injectable Generics Sales Price Trend (2012-2017)
    6.2 Taiwan Specialty Injectable Generics Sales Volume and Market Share by Type
    6.3 Taiwan Specialty Injectable Generics Sales Volume and Market Share by Application

7 India Specialty Injectable Generics (Volume, Value and Sales Price)
    7.1 India Specialty Injectable Generics Sales and Value (2012-2017)
        7.1.1 India Specialty Injectable Generics Sales Volume and Growth Rate (2012-2017)
        7.1.2 India Specialty Injectable Generics Revenue and Growth Rate (2012-2017)
        7.1.3 India Specialty Injectable Generics Sales Price Trend (2012-2017)
    7.2 India Specialty Injectable Generics Sales Volume and Market Share by Type
    7.3 India Specialty Injectable Generics Sales Volume and Market Share by Application

8 Southeast Asia Specialty Injectable Generics (Volume, Value and Sales Price)
    8.1 Southeast Asia Specialty Injectable Generics Sales and Value (2012-2017)
        8.1.1 Southeast Asia Specialty Injectable Generics Sales Volume and Growth Rate (2012-2017)
        8.1.2 Southeast Asia Specialty Injectable Generics Revenue and Growth Rate (2012-2017)
        8.1.3 Southeast Asia Specialty Injectable Generics Sales Price Trend (2012-2017)
    8.2 Southeast Asia Specialty Injectable Generics Sales Volume and Market Share by Type
    8.3 Southeast Asia Specialty Injectable Generics Sales Volume and Market Share by Application

9 Australia Specialty Injectable Generics (Volume, Value and Sales Price)
    9.1 Australia Specialty Injectable Generics Sales and Value (2012-2017)
        9.1.1 Australia Specialty Injectable Generics Sales Volume and Growth Rate (2012-2017)
        9.1.2 Australia Specialty Injectable Generics Revenue and Growth Rate (2012-2017)
        9.1.3 Australia Specialty Injectable Generics Sales Price Trend (2012-2017)
    9.2 Australia Specialty Injectable Generics Sales Volume and Market Share by Type
    9.3 Australia Specialty Injectable Generics Sales Volume and Market Share by Application

10 Asia-Pacific Specialty Injectable Generics Players/Suppliers Profiles and Sales Data
    10.1 Pfizer
        10.1.1 Company Basic Information, Manufacturing Base and Competitors
        10.1.2 Specialty Injectable Generics Product Category, Application and Specification
            10.1.2.1 Product A
            10.1.2.2 Product B
        10.1.3 Pfizer Specialty Injectable Generics Sales, Revenue, Price and Gross Margin (2012-2017)
        10.1.4 Main Business/Business Overview
    10.2 Fresenius
        10.2.1 Company Basic Information, Manufacturing Base and Competitors
        10.2.2 Specialty Injectable Generics Product Category, Application and Specification
            10.2.2.1 Product A
            10.2.2.2 Product B
        10.2.3 Fresenius Specialty Injectable Generics Sales, Revenue, Price and Gross Margin (2012-2017)
        10.2.4 Main Business/Business Overview
    10.3 Mylan N.V.
        10.3.1 Company Basic Information, Manufacturing Base and Competitors
        10.3.2 Specialty Injectable Generics Product Category, Application and Specification
            10.3.2.1 Product A
            10.3.2.2 Product B
        10.3.3 Mylan N.V. Specialty Injectable Generics Sales, Revenue, Price and Gross Margin (2012-2017)
        10.3.4 Main Business/Business Overview
    10.4 Teva Pharmaceutical
        10.4.1 Company Basic Information, Manufacturing Base and Competitors
        10.4.2 Specialty Injectable Generics Product Category, Application and Specification
            10.4.2.1 Product A
            10.4.2.2 Product B
        10.4.3 Teva Pharmaceutical Specialty Injectable Generics Sales, Revenue, Price and Gross Margin (2012-2017)
        10.4.4 Main Business/Business Overview
    10.5 Hikma Pharmaceuticals
        10.5.1 Company Basic Information, Manufacturing Base and Competitors
        10.5.2 Specialty Injectable Generics Product Category, Application and Specification
            10.5.2.1 Product A
            10.5.2.2 Product B
        10.5.3 Hikma Pharmaceuticals Specialty Injectable Generics Sales, Revenue, Price and Gross Margin (2012-2017)
        10.5.4 Main Business/Business Overview
    10.6 Novartis AG
        10.6.1 Company Basic Information, Manufacturing Base and Competitors
        10.6.2 Specialty Injectable Generics Product Category, Application and Specification
            10.6.2.1 Product A
            10.6.2.2 Product B
        10.6.3 Novartis AG Specialty Injectable Generics Sales, Revenue, Price and Gross Margin (2012-2017)
        10.6.4 Main Business/Business Overview
    10.7 Uman Pharma
        10.7.1 Company Basic Information, Manufacturing Base and Competitors
        10.7.2 Specialty Injectable Generics Product Category, Application and Specification
            10.7.2.1 Product A
            10.7.2.2 Product B
        10.7.3 Uman Pharma Specialty Injectable Generics Sales, Revenue, Price and Gross Margin (2012-2017)
        10.7.4 Main Business/Business Overview
    10.8 Baxter
        10.8.1 Company Basic Information, Manufacturing Base and Competitors
        10.8.2 Specialty Injectable Generics Product Category, Application and Specification
            10.8.2.1 Product A
            10.8.2.2 Product B
        10.8.3 Baxter Specialty Injectable Generics Sales, Revenue, Price and Gross Margin (2012-2017)
        10.8.4 Main Business/Business Overview
    10.9 Par Pharmaceutical
        10.9.1 Company Basic Information, Manufacturing Base and Competitors
        10.9.2 Specialty Injectable Generics Product Category, Application and Specification
            10.9.2.1 Product A
            10.9.2.2 Product B
        10.9.3 Par Pharmaceutical Specialty Injectable Generics Sales, Revenue, Price and Gross Margin (2012-2017)
        10.9.4 Main Business/Business Overview
    10.10 Sagent Pharmaceuticals
        10.10.1 Company Basic Information, Manufacturing Base and Competitors
        10.10.2 Specialty Injectable Generics Product Category, Application and Specification
            10.10.2.1 Product A
            10.10.2.2 Product B
        10.10.3 Sagent Pharmaceuticals Specialty Injectable Generics Sales, Revenue, Price and Gross Margin (2012-2017)
        10.10.4 Main Business/Business Overview
    10.11 Teligent

11 Specialty Injectable Generics Manufacturing Cost Analysis
    11.1 Specialty Injectable Generics Key Raw Materials Analysis
        11.1.1 Key Raw Materials
        11.1.2 Price Trend of Key Raw Materials
        11.1.3 Key Suppliers of Raw Materials
        11.1.4 Market Concentration Rate of Raw Materials
    11.2 Proportion of Manufacturing Cost Structure
        11.2.1 Raw Materials
        11.2.2 Labor Cost
        11.2.3 Manufacturing Expenses
    11.3 Manufacturing Process Analysis of Specialty Injectable Generics

12 Industrial Chain, Sourcing Strategy and Downstream Buyers
    12.1 Specialty Injectable Generics Industrial Chain Analysis
    12.2 Upstream Raw Materials Sourcing
    12.3 Raw Materials Sources of Specialty Injectable Generics Major Manufacturers in 2016
    12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders
    13.1 Marketing Channel
        13.1.1 Direct Marketing
        13.1.2 Indirect Marketing
        13.1.3 Marketing Channel Development Trend
    13.2 Market Positioning
        13.2.1 Pricing Strategy
        13.2.2 Brand Strategy
        13.2.3 Target Client
    13.3 Distributors/Traders List

14 Market Effect Factors Analysis
    14.1 Technology Progress/Risk
        14.1.1 Substitutes Threat
        14.1.2 Technology Progress in Related Industry
    14.2 Consumer Needs/Customer Preference Change
    14.3 Economic/Political Environmental Change

15 Asia-Pacific Specialty Injectable Generics Market Forecast (2017-2022)
    15.1 Asia-Pacific Specialty Injectable Generics Sales Volume, Revenue and Price Forecast (2017-2022)
        15.1.1 Asia-Pacific Specialty Injectable Generics Sales Volume and Growth Rate Forecast (2017-2022)
        15.1.2 Asia-Pacific Specialty Injectable Generics Revenue and Growth Rate Forecast (2017-2022)
        15.1.3 Asia-Pacific Specialty Injectable Generics Price and Trend Forecast (2017-2022)
    15.2 Asia-Pacific Specialty Injectable Generics Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
        15.2.1 Asia-Pacific Specialty Injectable Generics Sales Volume and Growth Rate Forecast by Region (2017-2022)
        15.2.2 Asia-Pacific Specialty Injectable Generics Revenue and Growth Rate Forecast by Region (2017-2022)
        15.2.3 China Specialty Injectable Generics Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.4 Japan Specialty Injectable Generics Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.5 South Korea Specialty Injectable Generics Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.6 Taiwan Specialty Injectable Generics Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.7 India Specialty Injectable Generics Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.8 Southeast Asia Specialty Injectable Generics Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.9 Australia Specialty Injectable Generics Sales, Revenue and Growth Rate Forecast (2017-2022)
    15.3 Asia-Pacific Specialty Injectable Generics Sales, Revenue and Price Forecast by Type (2017-2022)
        15.3.1 Asia-Pacific Specialty Injectable Generics Sales Forecast by Type (2017-2022)
        15.3.2 Asia-Pacific Specialty Injectable Generics Revenue Forecast by Type (2017-2022)
        15.3.3 Asia-Pacific Specialty Injectable Generics Price Forecast by Type (2017-2022)
    15.4 Asia-Pacific Specialty Injectable Generics Sales Forecast by Application (2017-2022)

16 Research Findings and Conclusion

17 Appendix
    17.1 Methodology/Research Approach